Volume 30, Number 7—July 2024
Synopsis
Strategies to Enhance COVID-19 Vaccine Uptake among Prioritized Groups, Uganda–Lessons Learned and Recommendations for Future Pandemics
Table 2
Vaccination model | CDC PEPFAR implementing partners |
Total no. (%) | ||||
---|---|---|---|---|---|---|
IDI-KHP | IDI-WHP | Mildmay Uganda | TASO | RHSP | ||
Point-of-care | 4,096 | 427 | 0 | 787 | 3,020 | 8,330 (11) |
Place of worship | 27,284 | 330 | 0 | 316 | 570 | 28,500 (38) |
Place of work | 2,711 | 1,000 | 0 | 1891 | 200 | 5,802 (8) |
SAGE | 694 | 13,731 | 1,808 | 16,233 | 0 | 32,466 (43) |
Total | 34,785 | 15,488 | 1,808 | 19,227 | 3,790 | 75,098 (100) |
*CDC, Centers for Disease Control and Prevention; IDI-KHP, Infectious Diseases Institute–Kampala HIV Project; IDI-WHP, Infectious Diseases Institute–West Nile HIV Project; PEPFAR, US President’s Emergency Plan for AIDS Relief; RHSP, Rakai Health Sciences Program; SAGE, Social Assistance Grant for Empowerment; TASO, The AIDS Support Organization.
Page created: May 23, 2024
Page updated: June 22, 2024
Page reviewed: June 22, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.